Lung cancer is the leading cause of cancer deaths worldwide. Like any other type of cancer, this condition is the result of abnormalities in the cells. Lung cancer can begin in any part of the organ, but in up to 95% of cases, the disease begins in the epithelial cells, which line the bronchi and bronchioles. The condition can also arise from the pleura and supporting tissues, such as the blood vessels.
Lung cancer patients who seek advanced but affordable treatment can travel to Southeast Asia, which is now considered one of the most trusted and reliable medical tourism destinations in the world. The region is deeply committed to becoming the global leader in the field of medical tourism and thus invests heavily in its medical infrastructure and in improving its healthcare system.
Lung cancer patients who consider travelling to Southeast Asia for treatment have the option to travel to Singapore, Thailand, or Malaysia. Singapore is globally recognised for having one of the best healthcare systems in the world and is the only developed country in Southeast Asia. It features all medical technological advances used in Western countries and dedicated cancer care facilities that offer specialist treatment that meets international standards. Thailand and Malaysia also offer the same quality of care at a much affordable cost. These countries are home to some of the world’s best oncologists with international training and decades of professional experience.
All three Southeast Asian countries have many Joint Commission International (JCI)-accredited hospitals that offer all types of treatment that lung cancer patients may require. This ranges from surgical procedures for the removal of the tumour to palliative and supportive care that aims to reduce or relieve symptoms so patients can enjoy a better quality of life.